Femtech Market worth $92.51 billion by 2030, growing at a CAGR of 14.47% - Exclusive Report by 360iResearch

The "Femtech Market by Offering (Products, Services, Software), Application (Fitness & Nutrition, General Health, Gynecology & Sexual Health), End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Femtech Market to grow from USD 35.91 billion in 2023 to USD 92.51 billion by 2030, at a CAGR of 14.47%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/femtech?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Femtech focuses on addressing the needs of U.S. women from a technological standpoint and encompasses several products and services developed to improve women's health and safety. These include products related to fertility tracking, contraception, maternal health, sexual wellness, mental health, work-life balance, and financial security, among others. Femtech is quickly becoming an important part of the U.S. healthcare landscape as it seeks to improve women's health with innovative solutions tailored to their unique needs and preferences. As women's healthcare enables better outcomes for society, female patients, consumers, and other stakeholders across the value chain, the demand for fintech is rapidly increasing. The high percentage of working women and the growing federal government focus on enhancing women's health drives the usage of femtech products and services in the United States. On the contrary, the lack of support from emerging U.S. countries for women's health and cybersecurity concerns hinders market growth. However, the development of novel femtech products and services, the rising number of consumer-centric startups, and the increasing availability of customized products are expected to accelerate their usage in the coming years in the United States.

The femtech market in the Americas region is evolving due to women's high integration of femtech products & services, a large share of market players in North America, the gradual adoption of femtech products, and the emergence of new startups in South America. Telemedicine platforms provide more accessible and affordable healthcare solutions for U.S. women, specifically in rural areas with limited access to specialized care providers. Artificial intelligence (AI) and efficient data analytics are also playing an increasingly important role in femtech product development in the country. AI-driven algorithms can help predict fertility windows, monitor hormonal cycles, and offer personalized insights into U.S. women's health issues based on their unique physiological data. The rise in female entrepreneurship is another notable trend as more women-founded startups enter the femtech market in the United States with innovative ideas focused on addressing unmet female healthcare needs. This growing representation of female entrepreneurs ensures that products are designed with U.S. women's perspectives in mind and also promotes gender equality within the technology sector. Thus, these key trends indicate a promising future for femtech within the United States as technological advancements prioritize and address women-specific health issues through improved accessibility, data-driven personalization, telehealth services, and increased representation of female entrepreneurs.

Market Segmentation & Coverage:

This research report categorizes the Femtech Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Offering, market is studied across Products, Services, and Software. The Products is further studied across Consumer Products, Home Testing Kits, and Trackers & Wearables. The Services is further studied across Benefits & Financing, Clinical Diagnostics, Patient Support, and Virtual Care. The Software is further studied across Fertility Management & Assisted Reproductive Technology Apps and Fitness Trackers. The Products commanded largest market share of 52.02% in 2023, followed by Software.

Based on Application, market is studied across Fitness & Nutrition, General Health, Gynecology & Sexual Health, and Mental Health. The Gynecology & Sexual Health is further studied across Menopause, Menstrual Health, and Pregnancy & Postpartum Care. The Gynecology & Sexual Health commanded largest market share of 33.61% in 2023, followed by General Health.

Based on End-Use, market is studied across Personal and Professional. The Professional is further studied across Diagnostic Centers, Fertility Clinics, and Hospitals. The Professional commanded largest market share of 63.38% in 2023, followed by Personal.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.35% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/femtech?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Femtech Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Femtech Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Femtech Market, highlighting leading vendors and their innovative profiles. These include Allara Health, Apple Inc., Athena Feminine Technologies, Inc., AVA Sciences-FMTC LLC, Bloomlife, Canopie Inc., Caraway, Inc., Carrot Fertility, Inc., Chiaro Technology Limited, Chorus Health Inc., Cleo Labs, Inc., Clue by Biowink GmbH, Elektra Health, Everlywell, Inc., Fitbit LLC by Google, Inc., Flo Health UK Limited, FOLX Health, Inc., Future Family, Inc., Garmin Ltd., Glow Inc., INTIMINA, Kindbody, Koninklijke Philips N.V., Maven Clinic Co., NextGen Jane, Nuvo Group Ltd., Organon & Co., Renovia Inc., Rosy Wellness, Inc., Rume Medical Group, Inc., Samsung Electronics Co., Ltd., Thirty Madison company, Tia, Inc., Unified Women's Healthcare, Univfy Inc., Willow Innovations, Inc., and Wolomi.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Femtech Market, by Offering
7. Femtech Market, by Application
8. Femtech Market, by End-Use
9. Americas Femtech Market
10. Asia-Pacific Femtech Market
11. Europe, Middle East & Africa Femtech Market
12. Competitive Landscape
13. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Femtech Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Femtech Market?
3. What is the competitive strategic window for opportunities in the Femtech Market?
4. What are the technology trends and regulatory frameworks in the Femtech Market?
5. What is the market share of the leading vendors in the Femtech Market?
6. What modes and strategic moves are considered suitable for entering the Femtech Market?

Read More @ https://www.360iresearch.com/library/intelligence/femtech?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.